Search results
Earnings call: Avadel Pharmaceuticals posts strong Q1 2024 results By Investing.com
Investing.com· 3 days agoThe company has seen significant growth in patient enrollment and therapy initiation for their...
Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Reve
Guru Focus· 4 days agoOn May 8, 2024, Avadel Pharmaceuticals PLC (AVDL, Financial) released its 8-K filing, announcing its financial results for the first quarter ended March 31, 2024. The specialty pharmaceutical ...
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoThe first quarter of 2024 was marked by strong financial performance for our on-market products,...
Wellbutrin vs Adderall: Important Differences You Should Know
MediaFeed via AOL· 5 days agoAnxiety and depression are two common mental conditions — it’s estimated that about 40 million...
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Zacks via Yahoo Finance· 5 days agoThe figure beat our model estimate of $68.6 million. Product revenues in the first quarter benefited...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoJazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript May 1, 2024 Jazz...
Earnings call: Axsome Therapeutics sees robust growth in Q1 2024 By Investing.com
Investing.com· 6 days agoAxsome Therapeutics (NASDAQ: NASDAQ:AXSM) reported a significant year-over-year revenue increase of...
Prediction: These 2 Growth Stocks Could Triple By 2030
Motley Fool via Yahoo Finance· 2 days agoHowever, Axsome's innovative days aren't behind it, which may allow the company to continue...
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
InvestorPlace· 4 days agoWhispers and rumors of widespread cannabis legalization are growing louder. Although the last major...
Jazz Pharma to Fight FDA in Court Over Rival Sleep Drug Approval
Bloomberg Law· 4 days ago...district court that the FDA violated an orphan drug law when it approved a rival product. will take to the US District Court for the District of Columbia to argue its case against the Food and Drug Administration on whether the agency violated the Orphan Drug Act when it approved Avadel CNS...